​​​Drug resistance is a serious problem with a huge negative impact on public health and economic growth. We face this issue for almost all marketed drugs developed against any infectious diseases as well as for the drugs used in the treatment of cancer and other non-communicable conditions. Considering that drug research and development is a long and highly complex process, drug resistance urges us to better understand the drug resistance mechanisms and develop new strategies to possibly avoid the issue or at least to have longer lasting drugs. This talk will discuss the computational approaches and tools that we have developed over the years with the applications to understand resistance mechanisms on HIV, TB and cancer drugs. The talk will also include research on developing pan-inhibitors against the malarial parasite.

More information: https://bit.ly/3vNzxhV​